B
BlueWind Medical
Evelops and markets an innovative wireless neuro-stimulation device for the treatment of peripheral neuropathic pain
About BlueWind Medical
BlueWind Medical is a healthcare startup that offers a revolutionary treatment for Urge Urinary Incontinence (UUI), a condition characterized by urgent bladder leaks. The company's flagship product, Revi, is a miniature device implanted near the ankle. This device sends signals to the bladder via nerves, helping manage UUI symptoms.
The company primarily serves patients suffering from UUI, a widespread condition that can significantly impact quality of life. The market for such a solution is substantial, given the prevalence of UUI and the lack of effective long-term treatments.
BlueWind Medical operates on a business-to-consumer model, selling its product directly to patients through healthcare providers. The company generates revenue from the sale of the Revi device and potentially from follow-up services related to the device's adjustment and maintenance.
Revi has shown promising results in clinical studies, with 8 out of 10 participants experiencing a reduction in leaks after one year. The device is implanted in a single outpatient procedure under local anesthesia, making it a convenient and less invasive treatment option.
In summary, BlueWind Medical is a promising startup offering a novel, effective, and convenient solution for UUI, a condition that affects a significant portion of the population.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2010
- Headquarters
- Herzliya, Israel
- Employees
- 93
- Open positions
- 3
- Dealroom signal
- 66.4/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Neurology, Mental Health, Neuromodulation and Neurostimulation, Tech for Medical Professionals, Tech for Patients, Biotech and Pharma
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBTDebt | May 2026 | $24M | — | Undisclosed | ↗ |
| LATE VCOther financing | May 2026 | $24M | $320M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for BlueWind Medical is 2.4K monthly website visits, down 17.2% over the last three months. BlueWind Medical's team declined 6.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
ConvaTec
Series B and later1 investor entered at this stage
Armentum Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about BlueWind Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BlueWind Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.